Keeley-Teton Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$704K Sell
47,310
-13
-0% -$200 0.09% 255
2024
Q4
$706K Sell
47,323
-7,778
-14% -$127K 0.08% 257
2024
Q3
$1.05M Sell
55,101
-1,315
-2% -$27.3K 0.12% 232
2024
Q2
$1.17M Buy
56,416
+402
+0.7% +$7.99K 0.15% 199
2024
Q1
$1.05M Buy
56,014
+1,487
+3% +$25.5K 0.13% 207
2023
Q4
$786K Sell
54,527
-4,128
-7% -$56.2K 0.1% 227
2023
Q3
$1.02M Sell
58,655
-41,679
-42% -$869K 0.14% 204
2023
Q2
$2.09M Sell
100,334
-24,829
-20% -$540K 0.27% 122
2023
Q1
$2.94M Buy
125,163
+3,528
+3% +$94.7K 0.36% 90
2022
Q4
$3.4M Sell
121,635
-1,270
-1% -$32.5K 0.42% 81
2022
Q3
$2.88M Buy
122,905
+5,036
+4% +$152K 0.39% 93
2022
Q2
$3.98M Buy
117,869
+4,572
+4% +$160K 0.5% 76
2022
Q1
$3.96M Sell
113,297
-646
-0.6% -$22.1K 0.41% 85
2021
Q4
$3.47M Buy
113,943
+30,384
+36% +$990K 0.37% 91
2021
Q3
$2.74M Sell
83,559
-5,088
-6% -$163K 0.3% 106
2021
Q2
$2.68M Buy
+88,647
New +$2.92M 0.28% 108

Other funds holding OGN

Keeley-Teton Advisors's OGN Position: Q1 2025 in Review

Keeley-Teton Advisors reduced its Organon & Co (OGN) stake by 0.03% in Q1 2025, selling an estimated $200 and leaving 47,310 shares worth $704K. The position accounts for 0.09% of the portfolio, ranked #255.

Keeley-Teton Advisors first reported a position in OGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.98M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Keeley-Teton Advisors held 47,310 shares of Organon & Co worth $704K as of Q1 2025.
  • Keeley-Teton Advisors sold 13 Organon & Co shares in Q1 2025, an estimated $200.
  • Organon & Co made up 0.09% of Keeley-Teton Advisors's portfolio in Q1 2025, its #255 holding.
  • Keeley-Teton Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 16 quarters since.
  • Keeley-Teton Advisors's Organon & Co position peaked at $3.98M in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Keeley-Teton Advisors's 13F filing for Q1 2025, filed 14 May 2025.